Aug 14, 2025 20:05
NSRX - Nasus Pharma Ltd.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 7.76 0.14 (1.8%) | --- | --- | --- | --- | 0.14 (1.8%) | --- | --- |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
Category:
/stock/categories/na
Market Period:
PreMarket
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 54.35
- VWAP:
- 7.88
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|